BillionToOne Inc.
Nasdaq BLLN · Menlo Park, CA
Works in Cardiovascular · Genetic & rare · Hematology · Metabolic & endocrine · Musculoskeletal · Neurology
BillionToOne Inc. is a clinical trial sponsor based in Menlo Park, CA, listed as Nasdaq BLLN. It has 1 active clinical trial with 1,000 planned participants, across 6 therapeutic areas.
Trial track record · since 2021
Financials · Nasdaq BLLN
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about BillionToOne Inc
BillionToOne Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 1,000 planned participants, in Cardiovascular, Genetic & rare, Hematology, Metabolic & endocrine and other areas. Since 2021 it has completed 0 trials and stopped 0 early.
BillionToOne Inc is based in Menlo Park, CA and is listed as Nasdaq BLLN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with BillionToOne Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.
Approve Suite is not affiliated with BillionToOne Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.